WHO Trial Finds Remdesivir Has ‘No Meaningful Effect’ In COVID-19 Patients

Boxes containing vials of remdesivir at a pharmaceutical company in Giza, Egypt.

The medicine is one of the few to win regulatory approval as a treatment for the disease, but has fallen out of favor with the health authority.

(Image credit: Fadel Dawood/DPA/Picture Alliance via Getty Images)

Read the full post on Health Care : NPR